Back to Journals » Therapeutics and Clinical Risk Management » Volume 14

Tanezumab: a selective humanized mAb for chronic lower back pain

Total article views   HTML views PDF downloads Totals
27,840 Dovepress* 22,844+ 1,890 24,734
PubMed Central* 4,996 718 5,714
Totals 27,840 2,608 30,448
*Since 21 February 2018
Total mentioned Facebook Delicious Reddit Twitter Others
4 0 0 0 1 3

View citations on PubMed Central and Google Scholar